Company profile
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
263080143
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Contineum Therapeutics, Inc.
11 Apr 24
3
Contineum Therapeutics, Inc.
4 Apr 24
4
Oyster Point Pharma, Inc.
4 Jan 23
4
Tempest Therapeutics, Inc.
3 May 22
4
Oyster Point Pharma, Inc.
7 Jan 22
4
Oyster Point Pharma, Inc.
23 Dec 21
4
Oyster Point Pharma, Inc.
20 Oct 21
3
Tempest Therapeutics, Inc.
6 Jul 21
4
Oyster Point Pharma, Inc.
14 May 21
4
Oyster Point Pharma, Inc.
30 Mar 21
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Apr 24 | Versant Venture Capital VI | Class A Common Stock | Conversion | Acquire C | Yes | No | 0 | 148,312 | 0.00 | 148,312 |
9 Apr 24 | Versant Venture Capital VI | Class A Common Stock | Conversion | Acquire C | Yes | No | 0 | 2,531 | 0.00 | 2,531 |
9 Apr 24 | Versant Venture Capital VI | Class A Common Stock | Conversion | Acquire C | Yes | No | 0 | 391,785 | 0.00 | 391,785 |
9 Apr 24 | Versant Venture Capital VI | Series C Preferred Stock Class B Common Stock | Conversion | Acquire C | Yes | No | 0 | 275,769 | 0.00 | 710,494 |
9 Apr 24 | Versant Venture Capital VI | Series C Preferred Stock Class B Common Stock | Conversion | Acquire C | Yes | No | 0 | 689 | 0.00 | 12,123 |
9 Apr 24 | Versant Venture Capital VI | Series C Preferred Stock Class B Common Stock | Conversion | Acquire C | Yes | No | 0 | 110,187 | 0.00 | 1,934,776 |
9 Apr 24 | Versant Venture Capital VI | Series B Preferred Stock Class B Common Stock | Conversion | Acquire C | No | No | 0 | 317,988 | 0.00 | 1,741,107 |
9 Apr 24 | Versant Venture Capital VI | Series B Preferred Stock Class B Common Stock | Conversion | Acquire C | Yes | No | 0 | 434,725 | 0.00 | 434,725 |
9 Apr 24 | Versant Venture Capital VI | Series B Preferred Stock Class B Common Stock | Conversion | Acquire C | Yes | No | 0 | 2,182 | 0.00 | 11,434 |
9 Apr 24 | Versant Venture Capital VI | Series B Preferred Stock Class B Common Stock | Conversion | Acquire C | Yes | No | 0 | 348,143 | 0.00 | 1,824,589 |